Suppr超能文献

氟轻松丙酮化物植入物在伴有严重虹膜-晶状体膈破坏和顽固性黄斑囊样水肿的眼中的巩膜固定术:氟轻松环锚定技术(FLAT)

Scleral Fixation of the Fluocinolone Acetonide Implant in Eyes with Severe Iris-Lens Diaphragm Disruption and Recalcitrant CME: The Fluocinolone-Loop-Anchoring Technique (FLAT).

作者信息

Herold Tina R, Liegl Raffael, Koenig Susanna, Almarzooqi Ahmed, Priglinger Siegfried G, Wolf Armin

机构信息

Department of Ophthalmology, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.

Department of Ophthalmology, University Hospital, Technical University of Munich, Munich, Germany.

出版信息

Ophthalmol Ther. 2020 Mar;9(1):175-179. doi: 10.1007/s40123-020-00232-2. Epub 2020 Feb 13.

Abstract

INTRODUCTION

While proven to be an effective treatment for cystoid macular edema (CME) and diabetic macular edema, intravitreal steroid implants (IVSI) may cause undesirable side effects, including steroid-related glaucoma or migration into the anterior chamber in the case of iris-lens diaphragm disruption. Here we present a new surgical technique that allows for the easy implantation and subsequent fixation of the fluocinolone acetonide intravitreal implant without the risk of migration as a feasible and possibly reversible approach in the treatment of persistent CME in severely damaged eyes.

METHODS

In this single-center, prospective off-label, proof of principle, scleral fixation of the fluocinolone implant was performed in two eyes with disrupted anterior-posterior segment border and persistent CME. Both eyes were then followed monthly in accordance to a detailed protocol.

RESULTS

The procedure was overall well tolerated without severe side effects. There was no migration of the implant in the anterior chamber in either eye.

CONCLUSION

Scleral fixation of the fluocinolone implant proved to be a safe and feasible approach in eyes with persistent CME and disrupted anterior-posterior segment border. This new technique also allows for the possible removal of the implant and may therefore be suitable even for eyes at higher risk for side effects, such as glaucoma.

摘要

引言

虽然玻璃体内类固醇植入物(IVSI)已被证明是治疗黄斑囊样水肿(CME)和糖尿病性黄斑水肿的有效方法,但它可能会引起不良副作用,包括类固醇相关的青光眼,或者在虹膜 - 晶状体膈破裂的情况下迁移至前房。在此,我们介绍一种新的手术技术,该技术可使曲安奈德玻璃体内植入物易于植入并随后固定,且不存在迁移风险,是治疗严重受损眼睛中持续性CME的一种可行且可能可逆的方法。

方法

在这个单中心、前瞻性、非标签、原理验证研究中,对两只前后节边界中断且患有持续性CME的眼睛进行了曲安奈德植入物的巩膜固定术。然后按照详细方案对两只眼睛每月进行随访。

结果

该手术总体耐受性良好,无严重副作用。两只眼睛的植入物均未迁移至前房。

结论

对于患有持续性CME且前后节边界中断的眼睛,曲安奈德植入物的巩膜固定术被证明是一种安全可行的方法。这种新技术还允许可能取出植入物,因此甚至可能适用于发生副作用风险较高的眼睛,如青光眼患者的眼睛。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/636f/7054516/747e009ea2a5/40123_2020_232_Fig1_HTML.jpg

相似文献

2
Scleral fixation of fluocinolone acetonide implant.
Am J Ophthalmol Case Rep. 2020 Jun 12;19:100775. doi: 10.1016/j.ajoc.2020.100775. eCollection 2020 Sep.
4
Fluocinolone Acetonide 0.19 mg Implant in Patients with Cystoid Macular Edema Due To Irvine-Gass Syndrome.
Int Med Case Rep J. 2021 Feb 26;14:127-132. doi: 10.2147/IMCRJ.S295045. eCollection 2021.
7
[Studies on clinical pathophysiology of pseudophakic/aphakic eyes--a journey of 4 decades].
Nippon Ganka Gakkai Zasshi. 2008 Mar;112(3):214-45; discussion 246.
8
Anterior migration of intravitreal fluocinolone acetonide (Iluvien®) implant in a pseudophakic eye with intact posterior capsule.
Am J Ophthalmol Case Rep. 2020 Sep 11;20:100922. doi: 10.1016/j.ajoc.2020.100922. eCollection 2020 Dec.
9
Fluocinolone acetonide for the treatment of diabetic macular edema.
Expert Opin Pharmacother. 2017 Oct;18(14):1507-1516. doi: 10.1080/14656566.2017.1363182. Epub 2017 Aug 9.
10
Cystoid macular oedema and iris-fixated intraocular lens treated with intraocular lens exchange: A case series and review.
J Int Med Res. 2019 Jan;47(1):188-195. doi: 10.1177/0300060518799004. Epub 2018 Oct 1.

引用本文的文献

2
Intrascleral Tunnel Clamping of Fluocinolone Acetonide Implant: A Novel Scleral Fixation Technique.
Pharmaceuticals (Basel). 2025 Jun 6;18(6):849. doi: 10.3390/ph18060849.
4
Suprachoroidal Delivery of Corticosteroid Slow-Release Implants for the Treatment of Cystoid Macular Edema.
Klin Monbl Augenheilkd. 2025 Jun;242(6):674-676. doi: 10.1055/a-2541-2444. Epub 2025 Feb 17.
6
Off-Label Use of 0.19 mg Fluocinolone Acetonide Intravitreal Implant: A Systematic Review.
J Ophthalmol. 2021 May 17;2021:6678364. doi: 10.1155/2021/6678364. eCollection 2021.
7
Scleral fixation of fluocinolone acetonide implant.
Am J Ophthalmol Case Rep. 2020 Jun 12;19:100775. doi: 10.1016/j.ajoc.2020.100775. eCollection 2020 Sep.

本文引用的文献

1
Anterior segment migration of dexamethasone implant: risk factors, complications, and management.
Curr Opin Ophthalmol. 2017 May;28(3):246-251. doi: 10.1097/ICU.0000000000000365.
2
OBSERVATION: FLUOCINOLONE ACETONIDE (ILUVIEN) IMPLANT MIGRATION INTO THE ANTERIOR CHAMBER.
Retin Cases Brief Rep. 2017;11(1):44-46. doi: 10.1097/ICB.0000000000000284.
3
Dexamethasone implant as an effective treatment option for macular edema due to Irvine-Gass syndrome.
J Cataract Refract Surg. 2015 Sep;41(9):1954-61. doi: 10.1016/j.jcrs.2015.10.025.
4
Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema.
Ophthalmology. 2014 Oct;121(10):1892-903. doi: 10.1016/j.ophtha.2014.04.019. Epub 2014 Jun 14.
5
Scleral fixation of dexamethasone intravitreal implant (OZURDEX®) in a case of angle-supported lens implantation.
Int Ophthalmol. 2014 Jun;34(3):661-5. doi: 10.1007/s10792-013-9841-4. Epub 2013 Aug 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验